baber/WOPTO huggingface dataset:
Patent CA-2529852-A1 (CA)
Title: Compositions for and methods for treating hiv
Inventor: KIM JONG JOSEPH
IPC: A61K/
Filed: 2004-06-21
Abstract: Pharmaceutical composition comprising compounds and/or compositions useful to inhibit HIV replication are disclosed. Methods of treating individuals infected with HIV are disclosed. Methods of preventing HIV infection in high risk individuals are disclosed.
Patent CA-2531293-A1 (CA)
Title: Transaction verification system
Inventor: NARAINSAMY ADELE KATRINE
IPC: G06Q20/00
Filed: 2004-06-30
Abstract: A financial transaction verification system comprises a transaction-processing client, a transaction processing server under the control of a financial services provider, and a telecommunication client under the control of transaction initiator. The transaction processing client records data regarding the telecommunication client, and transmits the recorded data to the transaction processing server. The transaction processing server uses the received recorded data and the telecommunication client previously stored with the financial services provider to formulate a transaction authorization request to the telecommunication client. The transaction authorization request is transmitted from the transaction processing server to the telecommunication client. The telecommunication client is required to the entry of a correct authorization code as a precondition for further processing the transaction authorization request.
Patent CA-2533408-A1 (CA)
Title: Production of trimethylene carbonate from poly(trimethylene carbonate) by wiped film reactive evaporation
Inventor: GWYN DAVID ERIC
IPC: C07D319/06
Filed: 2004-07-22
Abstract: A method for producing trimethylene carbonate poly(trimethylene carbonate which comprises (a) introducing liquid poly(trimethylene carbonate) and an optional catalyst into a wiped film evaporator reactor under a vacuum 15 kPa or less, said reactor having walls heated to at least 230~C and an internal condenser heated to a temperature above the boiling point of trimethylene carbonate, (b) spreading the poly(trimethylene carbonate) into a thin film and allowing it to flow down the interior surface of the heated walls, (c) depolymerizing the poly(trimethylene carbonate) to form trimethylene carbonate which is driven to the internal condenser and residue poly(trimethylene carbonate) which continues down the reactor, and (d) collecting the trimethylene carbonate in a cooled distillate receiver.
Patent CA-2533626-A1 (CA)
Title: Quinolinone derivatives as inhibitors of c-fms kinase
Inventor: WALL MARK J
IPC: A61K31/4709
Filed: 2004-07-20
Abstract: The invention is directed to compounds of Formulae I and II, wherein R1, R2, R3, R5, R6, Y1, Y2, Y3, Y4 and X are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase.
Patent CA-2534861-A1 (CA)
Inventor: GUILE GRAHAM
IPC: B62B7/04
Filed: 2003-08-07
Abstract: L'invention concerne une roue multidirectionnelle (10) comprenant un cadre (11), ayant un moyeu central (12) tournant autour d'un axe principal et une pluralité de supports de galets (16) radialement espacés du moyeu central, une pluralité de galets espacés uniformément sur la circonférence de la roue (10) et montés pivotants sur les supports de galets (16). Les galets tournent autour d'une pluralité correspondante d'axes de galets alignés dans le plan de la roue et perpendiculaires à l'axe principal. Le cadre (11) est formé d'une seule pièce dans un premier procédé de moulage et les galets sont formés en place sur la roue (10) autour des supports de galets (16) dans un procédé distinct. Dans un autre mode de réalisation, une roue multidirectionnelle comprend une paire d'un premier et d'un deuxième cadres opposés formés séparément d'une seule pièce.
Patent CA-2537487-A1 (CA)
Title: Piperazine substituted compounds used as calcium channel blockers
Inventor: PAJOUHESH HASSAN
IPC: C07D295/02
Filed: 2004-09-03
Abstract: New piperazine substituted compounds of formula (1) have been found to be useful in treatinf conditions associated with calcium channel function. These piperazine derivatives are useful in treating conditions such as stroke, pain, anxiety disorders, depression, addiction, gastrointestinal disorders, genitourinary disorders, cardiovascular disease, epilepsy, diabetes and cancer.
Patent CA-2539577-A1 (CA)
Inventor: BALDERSTON GREG
IPC: B42D15/02
Filed: 2003-09-22
Abstract: This invention relates to a greeting card (10) that includes a candle (11), a first leaf (12), a second leaf (13), and an expandable receptacle (14), located intermediate said first and second leaves, which is adapted to receive the candle.
Patent CA-2539711-A1 (CA)
Title: Method and apparatus of fuelling an internal combustion engine with hydrogen and methane
IPC: F02B69/04
Filed: 2006-03-31
Abstract: A gaseous-fuelled internal combustion engine and a method of operating same are provided for improving combustion stability and reducing emissions of NOx, PM, and unburned hydrocarbons. The method comprises fuelling an internal combustion engine with hydrogen and natural gas, which can be directly injected into the combustion chamber together or introduced separately. Of the total gaseous fuel delivered to the engine, at least 5% by volume at standard temperature and pressure is hydrogen. For at least one engine operating condition, the ratio of fuel rail pressure to peak in-cylinder pressure is at least 1.5:1. The engine comprises a combustion chamber defined by a cylinder, a cylinder head, and a piston movable within the cylinder; and a fuel injection valve operable for introducing the gaseous fuel mixture directly into the combustion chamber, or two separate fuel injection valves for introducing the methane and hydrogen separately. An electronic controller is in communication with actuator(s) for the fuel injection valve(s) for controlling timing for operating the fuel injection valve(s). The engine has a compression ratio of at least 14:1.
Patent CA-2540325-A1 (CA)
Inventor: COLLI ENRICO
IPC: A61K31/59
Filed: 2004-09-24
Abstract: There is provided according to the invention the use of Vitamin D compounds such as 1-alpha-fluoro-25-hydroxy-16,23e-diene-26,27-bishomo-20-epi-cholecalciferol in the prevention or treatment of bladder dysfunction.
Patent CA-2543033-A1 (CA)
Title: Direct nucleic acid detection in bodily fluids
Inventor: LUKOWIAK ANDREW A
IPC: C12Q/
Filed: 2004-10-18
Abstract: The present invention provides methods and routines for developing and optimizing nucleic acid detection assays for use in basic research, clinical research, and for the development of clinical detection assays. In particular, the present invention provides methods for designing oligonucleotide primers to be used in multiplex amplification reactions. The present invention also provides methods to optimize multiplex amplification reactions. The present invention also provides methods for combined target and signal generation assays.
Patent CA-2543670-A1 (CA)
Inventor: JUTRAS MARTIN
IPC: F01D11/00
Filed: 2004-10-08
Abstract: A gas turbine engine expansion joint comprises first and second members having confronting faces defining a gap therebetween. At room temperature, the gap varies in accordance with the temperature distribution profile of the first and second members during normal engine operation.
Patent CA-2544118-A1 (CA)
Inventor: ALTMANN ANDRES CLAUDIO
IPC: A61B8/14
Filed: 2006-04-19
Abstract: A medical imaging system for imaging a patient's body includes a catheter having a position sensor and an ultrasonic imaging sensor wherein the position sensor transmits electrical signals indicative of positional information of a portion of the catheter in a patient's body and the ultrasonic imaging sensor transmits ultrasonic energy at a target in the patient's body, receives ultrasonic echoes reflected from the target in the patient's body and transmits signals relating to the ultrasonic echoes reflected from the target in the patient's body. A positioning processor is operatively connected to the catheter for determining positional information of the portion of the catheter based on the electrical signals transmitted by the position sensor.  The system also includes a display and an image processor operatively connected to the catheter, the positioning processor and the display. The image processor generates an ultrasonic image of the target based on the signals transmitted by the ultrasonic sensor and depicts in real-time the generated ultrasound image on a display in a same orientation as an orientation of the portion of the catheter in the patient's body based on positional information derived from the position sensor.
Patent CA-2551862-A1 (CA)
Title: Piperazines useful for treating pain
Inventor: SUN QUN
IPC: A61P17/00
Filed: 2004-12-17
Abstract: Compounds of formulae (I) and (II) where Ar1, Ar2, R3, R4, and m, are disclosed herein, or a pharmaceutically acceptable salt thereof (a "Nitro(cyano)vinylpiperazine Compound"); compositions comprising an effective amount of a Nitro(cyano)vinylpiperazine Compound; and methods for treating or preventing pain and other conditions in an animal comprising administering to an animal in need thereof an effective amount of a Nitro(cyano)vinylpiperazine Compound are disclosed.
Patent CA-2553355-A1 (CA)
Inventor: LOWLES ROBERT J
IPC: G02B6/00
Filed: 2006-07-25
Abstract: A shared light pipe is set forth for transmitting light generated by a message waiting LED in a mobile communication device, in one direction, and transmitting ambient or surrounding light, in an opposite direction, to a light sensor for controlling a display backlight of the device. The light pipe includes an elongated first portion having a first end for receiving and transmitting light and external surfaces for reflecting light there through via total internal reflection (TIR), a second portion coextensive with the first portion for outputting light received at the first end and reflected through the first portion, and a second branch coextensive with the first portion for receiving and transmitting light for output at the first end.
Patent CA-2555763-A1 (CA)
Title: Therapeutic agent for vasospasm accompanying bypass operation
Inventor: SHIMOKAWA HIROAKI
IPC: A61K31/4375
Filed: 2005-01-27
Abstract: An agent and composition for the prevention of and treatments for vasospasm accompanying a bypass operation, which each contains as an active ingredient either a compound represented by the general formula (I) or an acid addition salt or hydrate thereof. (In the formula, R1 represents hydrogen or hydroxy.) The agent and composition for the prevention of and treatments for vasospasm accompanying a bypass operation is effective in the prevention of or treatments for vasospasm accompanying a bypass operation.
Patent CA-2555916-A1 (CA)
Title: Surchaussure antiderapante
Inventor: LARSON JON C
IPC: A43B1/10
Filed: 2005-02-18
Abstract: L'invention concerne une surchaussure antidérapante qui comprend une bande extérieure de contour, une surface antidérapante disposée à l'intérieur de la bande extérieure de contour permettant d'assurer une traction, et une structure en bande reliant la surface antidérapante à la bande extérieure de contour. La surface antidérapante peut comprendre des nervures antidérapantes permettant d'assurer une traction. La surface antidérapante peut comprendre également des espaces entre les nervures permettant d'assurer une traction. La surface antidérapante peut comprendre en outre des dispositifs antidérapants amovibles permettant d'assurer une traction. L'invention concerne également un procédé de production d'une surchaussure antidérapante qui consiste à utiliser une bande extérieure de contour, une surface antidérapante disposée à l'intérieur de la bande extérieure de contour, et une structure en bande reliant la surface antidérapante à la bande extérieure de contour.
Patent CA-2559587-A1 (CA)
Title: Hot dip galvanized composite high strength steel sheet excellent in shapeability and hole enlargement ability and method of production of same
Inventor: NONAKA TOSHIKI
IPC: C23C2/40
Filed: 2005-02-28
Abstract: The present invention provides a hot dip galvanized composite high strength steel sheet excellent in shapeability and hole enlargement ability and a method of production of the same, that is, a hot dip galvanized composite high strength steel sheet excellent in shapeability and hole enlargement ability containing C:  0.01 to 0.3%, Si: 0.005 to 0.6%, Mn: 0.1 to 3.3%, P:  0.001 to 0.06%, S: 0.001 to 0.01%, Al: 0.25 to 1.8%, and N: 0.0005 to 0.01% and having a metal structure of ferrite and, by area-rate, 5% to 60% of tempered martensite and a method of production of the same comprising hot rolling, then cold rolling a slab including the above ingredients, heating the sheet in the hot dip galvanization heating process to Ac1 to Ac3+100°C, holding it there for 30 seconds to 30 minutes, then cooling it by a 1°C/s or higher cooling rate to 450 to 600°C, hot dip galvanizing it at that temperature, then cooling it at a 1°C/s or higher cooling rate to the martensite transformation point or lower in temperature, holding it there at 200°C to 500°C for 1 second to 5 minutes, then cooling it at a 5°C/s or higher cooling rate to 100°C or less.
Patent CA-2560011-A1 (CA)
Inventor: PRENDERGAST CLODAGH
IPC: C12Q1/68
Filed: 2005-03-22
Abstract: The invention relates to nucleic acids and polypeptides referred to herein as cospeptin and cosmedin. Cospeptin, cosmedin, analogs and mimetics thereof act in signaling pathways, and are shown to modulate hypertension and other cardiovascular parameters, and gastric emptying. Cospeptin and cosmedin nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing the polypeptide; and in studying associated physiological pathways.
Patent CA-2560123-A1 (CA)
Inventor: GYDESEN ERIK
IPC: F16K15/14
Filed: 2005-03-12
Abstract: There is described a method and a system for cleaning an ink chamber (1) of a printing unit. The system includes a storage tank (10) which via a high-pressure pump (9) is connected with a hydrophore (2). In the hydrophore a high pressure is built up, and the hydrophore is connected with cleaning nozzles (40) via a valve (5). Thus it becomes possible to inject a shot of cleaning liquid into the chamber by switching the valves (5). The cleaning nozzles are preferably designed as a mushroom-shaped plug (40) with a stem (41) which is mounted in the chamber wall and which has a circular domed top (43) of elastic, resilient material. When injecting cleaning liquid, the elastic plug will spray cleaning liquid out into the chamber, and after shutting off the pres~sure, there will be a self-closing effect.
Patent CA-2560711-A1 (CA)
Title: Portable type fastener driving tool
Inventor: YAMAKAWA KEIJI
IPC: B25C1/00
Filed: 2005-03-30
Abstract: A gas combustion type coil nailer is provided with (a) a main body (1) which is provided with combustion chamber; (b) a head part (3) which is disposed on the front surface of this; and (c) a magazine 4 which is disposed on the bottom surface of the head part (3) so that it can be attached and detached easily. A coil shaped nail connecting body is loaded onto the magazine (4).  The head part (3) is provided with (d) a guide tube (35) through which the rod (17) and the nail n pass; and (e) with a feed motor (47). The nail connecting body N is fed to the guide tube (35) by a feed gear which is driven by the feed motor (47). Power is supplied to the feed motor (47) from a battery. The rod (17) is driven and the nail is fed by separate motive forces so that the nail can be fed reliably without adversely affecting the accuracy and reliability of the driving capacity of the rod (17).
Patent CA-2560944-A1 (CA)
Inventor: CLARKE ADRIENNE E
IPC: C12N15/29
Filed: 2005-03-31
Abstract: Methods for fostering somatic embryogenic competence of a plant cell or tissue by contacting the plant cell or tissue with an arabinogalactan protein (AGP) composition effective for fostering somatic embryogenic competence in plant species and varieties that are recalcitrant to somatic embryogenesis and/or regeneration are provided. AGP compositions useful for fostering somatic embryogenic competence are provided, including total AGP and an AGP RP-HPLC  hydrophobic fraction, both from embryogenic callus, from plant varieties including cotton lines Coker 315, Siokra 1-4, and Sicala 40, including at concentrations ranging from about 0.0008 mg/L to about 100 mg/L. Methods for regenerating plants, producing transformed plants, and impeding somatic embryogenic competence are also provided. Plant culture media and methods for making useful AGP compositions and media are also provided. Amino acid and nucleotide sequences for peptides and proteins eluting in hydrophobic AGP  fractions are also provided.
Patent CA-2565445-A1 (CA)
Title: Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases
Inventor: ZELDIS JEROME B
IPC: A61K31/405
Filed: 2004-05-05
Abstract: Methods of treating, preventing and/or managing a myeloproliferative disease are disclosed. Specific methods encompass the administration of a selective cytokine inhibitory drug, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent, and/or the transplantation of blood or cells.  Particular second active agent is capable of suppressing the overproduction of hematopoietic stem cells or ameliorating one or more of the symptoms of MPD.  Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Patent CA-2567836-A1 (CA)
Title: Treatment with gemcitabine and an egfr-inhibitor
Inventor: KOLINSKY KENNETH
IPC: A61K31/7072
Filed: 2005-05-27
Abstract: The present invention provides a method for manufacturing a medicament for treating tumors or tumor metastases, characterized in that a therapeutically effective amount of an EGFR kinase inhibitor and gemcitabine is used, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. The invention also encompasses a pharmaceutical composition that is comprised of an EGFR kinase inhibitor and gemcitabine combination in combination with a pharmaceutically acceptable carrier. A preferred example of an EGFR kinase inhibitor that can be used in practising this invention is the compound erlotinib HCl (also known as TarcevaTM).
Patent CA-2569120-A1 (CA)
Title: Circuit protection
Inventor: NELSON PAUL D
IPC: H01H87/00
Filed: 2006-11-28
Abstract: A circuit which is configured for connection between a voltage source and a load, and which is configured to function as an automatic, re-settable fuse with regard to providing current to the load. The circuit includes a switch and sensor, such as a field effect transistor (FET), which is connected to the voltage source and the load and which is configured to selectively provide current to the load, depending on whether an overload condition exists.  There is circuitry in communication with the FET which is configured to periodically send pulses to the FET in an attempt to re-set the switch and sensor during an overload condition.  The circuit is configured to stop providing current to the load during an overload condition, but is configured to provide current to the load upon the overload condition being rectified.  The circuitry which is in communication with the field effect transistor and which is configured to periodically send pulses thereto includes a timing circuit and an oscillator. Also included is a circuit speed controller which is configured to control how often the pulses are provided to field effect transistor.
Patent CA-2569157-A1 (CA)
Title: Wireless charging/power bypass system device
Inventor: SALAMON JOHN E
IPC: H02J7/00
Filed: 2006-11-20
Abstract: This system consists of 1 receiver/charging/inverter device and 1 integrated or 1 external receiving antenna. The integrated antenna can be disconnected to connect the external antenna. The receiver will consist of electronic components which will receive broadband signals from the air. The power in the frequencies that are received will be converted to DC. The DC  power will then be used to recharge the battery. The battery will supply the power needed run the inverter, which will convert the power to AC, and/or power 12VDC devices as well. The inverter will have 110VAC O/P, or 220VAC O/P, depending on the model, and will be used to power small items. The models will vary in size depending on the power required, as larger units will require larger inverters and larger batteries. The AC power receptacles will be different depending on wether the device has 110VAC outlets or 220VAC outlets. The typical system is expected to work anywhere that Radio Frequency signals or Electrical Magnetic Fields are present. The more power that is present in the air, in a particular area, the better the battery can be re-charged. If no signals are present to recharge the battery, an external power supply can be used to recharge the battery.
Patent CA-2571093-A1 (CA)
Title: 6-monoacetylmorphine derivatives useful in immunoassay
Inventor: ROOT RICHARD TERRY
IPC: G01N33/94
Filed: 2006-12-13
Abstract: Analogs of 6-monoacetyl morphine (6-MAM) are described. These include analogs derivatized at either the C-3 position, the C-6 position, or the nor position of the molecule. These analogs allow for elaboration with linkers terminated by a functional group such as an activated ester, the functional groups being useful for attaching the molecule to other entities such as proteins, polysaccharides, and reporter groups.
Patent CA-2571317-A1 (CA)
Title: Optical noninvasive vital sign monitor
Inventor: FOSTER KIRK S
IPC: A61B5/021
Filed: 2005-06-21
Abstract: An optical noninvasive vital sign motor comprising a reflectance-type optical sensor within a pressurizable capsule retained by a headband, the capsule having an optically transparent or translucent inner wall adapted for placement against a subject~s forehead. The optical sensor is mounted on the inside surface of the pressurizable capsule~s inner wall, which contacts the subject~s forehead during use, and includes a light source and a photodetector aimed toward the inside surface of the inner capsule wall. One embodiment of the vital sign monitor includes optical oscillometric circuit means responsive to an output signal from the optical sensor for determining systolic pressure, mean pressure and diastolic pressure during a transition in capsule pressure between a pressure greater than normal systolic pressure and a pressure less than normal diastolic pressure.
Patent CA-2574377-A1 (CA)
Title: Methods and apparatus for providing content information to content servers
Inventor: CHANDHOK RAVINDER
IPC: H04N7/173
Filed: 2005-07-21
Abstract: Methods and apparatus for maintaining program-guide records comprises the steps of requesting a program-guide index, receiving the program-guide index, and determining whether there exists any new program-guide record based on the received program-guide index. The method further comprises requesting a new program-guide record and receiving the program-guide record. In one aspect, a method for maintaining program-guide records comprises the steps of receiving a program-guide update indication, and determining any new program-guide record based on the received program-guide update indication. The method further comprises requesting an updated program-guide record, receiving the updated program-guide record, and updating the program-guide records.